BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14767549)

  • 1. Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles.
    Ochi K; Daigo Y; Katagiri T; Nagayama S; Tsunoda T; Myoui A; Naka N; Araki N; Kudawara I; Ieguchi M; Toyama Y; Toguchida J; Yoshikawa H; Nakamura Y
    Int J Oncol; 2004 Mar; 24(3):647-55. PubMed ID: 14767549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide.
    Bruheim S; Xi Y; Ju J; Fodstad O
    Clin Cancer Res; 2009 Dec; 15(23):7161-9. PubMed ID: 19920113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profile associated with response to doxorubicin-based therapy in breast cancer.
    Folgueira MA; Carraro DM; Brentani H; Patrão DF; Barbosa EM; Netto MM; Caldeira JR; Katayama ML; Soares FA; Oliveira CT; Reis LF; Kaiano JH; Camargo LP; Vêncio RZ; Snitcovsky IM; Makdissi FB; e Silva PJ; Góes JC; Brentani MM
    Clin Cancer Res; 2005 Oct; 11(20):7434-43. PubMed ID: 16243817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma.
    Kurokawa Y; Matoba R; Nagano H; Sakon M; Takemasa I; Nakamori S; Dono K; Umeshita K; Ueno N; Ishii S; Kato K; Monden M
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6029-38. PubMed ID: 15447987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
    Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.
    Zalupski MM; Rankin C; Ryan JR; Lucas DR; Muler J; Lanier KS; Budd GT; Biermann JS; Meyers FJ; Antman K
    Cancer; 2004 Feb; 100(4):818-25. PubMed ID: 14770440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
    Villeneuve DJ; Hembruff SL; Veitch Z; Cecchetto M; Dew WA; Parissenti AM
    Breast Cancer Res Treat; 2006 Mar; 96(1):17-39. PubMed ID: 16322897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
    Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
    Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An expression signature classifies chemotherapy-resistant pediatric osteosarcoma.
    Mintz MB; Sowers R; Brown KM; Hilmer SC; Mazza B; Huvos AG; Meyers PA; Lafleur B; McDonough WS; Henry MM; Ramsey KE; Antonescu CR; Chen W; Healey JH; Daluski A; Berens ME; Macdonald TJ; Gorlick R; Stephan DA
    Cancer Res; 2005 Mar; 65(5):1748-54. PubMed ID: 15753370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of risk of disease recurrence by genome-wide cDNA microarray analysis in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy.
    Zembutsu H; Yanada M; Hishida A; Katagiri T; Tsuruo T; Sugiura I; Takeuchi J; Usui N; Naoe T; Nakamura Y; Ohno R
    Int J Oncol; 2007 Aug; 31(2):313-22. PubMed ID: 17611687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
    Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
    Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.
    Györffy B; Serra V; Jürchott K; Abdul-Ghani R; Garber M; Stein U; Petersen I; Lage H; Dietel M; Schäfer R
    Oncogene; 2005 Nov; 24(51):7542-51. PubMed ID: 16044152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study.
    Thiele OC; Freier K; Bacon C; Egerer G; Hofele CM
    Br J Oral Maxillofac Surg; 2008 Oct; 46(7):533-6. PubMed ID: 18436357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein expression in high grade central osteosarcoma and normal bone cells. An immunohistochemical study.
    Pösl M; Amling M; Grahl K; Hentz M; Ritzel H; Werner M; Winkler K; Delling G
    Gen Diagn Pathol; 1997 Jun; 142(5-6):317-25. PubMed ID: 9228255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemia.
    Heuser M; Wingen LU; Steinemann D; Cario G; von Neuhoff N; Tauscher M; Bullinger L; Krauter J; Heil G; Döhner H; Schlegelberger B; Ganser A
    Haematologica; 2005 Nov; 90(11):1484-92. PubMed ID: 16266895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prediction of response to neoadjuvant chemotherapy in Barrett's carcinoma by quantitative gene expression analysis].
    Langer R; Specht K; Becker K; Ewald P; Sarbia M; Busch R; Feith M; Stein HJ; Siewert JR; Höfler H
    Verh Dtsch Ges Pathol; 2004; 88():207-13. PubMed ID: 16892554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate gene expression changes after the first course of neoadjuvant chemotherapy in patients with primary breast cancer disease.
    Modlich O; Prisack HB; Munnes M; Audretsch W; Bojar H
    Clin Cancer Res; 2004 Oct; 10(19):6418-31. PubMed ID: 15475428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic osteosarcoma.
    Daw NC; Billups CA; Rodriguez-Galindo C; McCarville MB; Rao BN; Cain AM; Jenkins JJ; Neel MD; Meyer WH
    Cancer; 2006 Jan; 106(2):403-12. PubMed ID: 16353204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of major vault protein gene in osteosarcoma patients.
    Dalla-Torre CA; de Toledo SR; Yoshimoto M; Petrilli AS; Andrade JA; Chilton-MacNeill S; Squire JA; Zielenska M
    J Orthop Res; 2007 Jul; 25(7):958-63. PubMed ID: 17415755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.